Oct 15 (Reuters) - Propanc Biopharma Inc PPCB.O:
PROPANC BIOPHARMA ANNOUNCES STRATEGIC FINANCING AGREEMENT OF UP TO $100 MILLION WITH HEXSTONE CAPITAL
PROPANC BIOPHARMA INC - PREFERRED STOCK CONVERTIBLE INTO COMMON STOCK AT $5.00 PER SHARE
Source text: ID:nGNX2VnrdF
Further company coverage: PPCB.O